Longhi (on Behalf Of), S., Mauer, M., Berk, J., Hanna, M., Gillmore, J., Vellosa–schwartzmann, P., Lairez, O., Hatano, M., Cho, H., Van Der Meer, P., White, M., Yureneva, E., Sweetser, M., Jay, P., Vest, J., & Fontana, M. (2024). PRIMARY RESULTS FROM APOLLO–B OPEN–LABEL EXTENSION STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS. European Heart Journal Supplements, 26(Supplement_2), ii1–ii1. https://doi.org/10.1093/eurheartjsupp/suae036.002

Longhi, S., Maurer, M., Fontana, M., Berk, J., Gustafsson, F., Simões, M., Grogan, M., Fernandes, F., Gottlieb, R., Kubanek, M., Poulsen, S., Damy, T., Diemberger, I., Tahara, N., Yu, W., Tang, W., Obici, L., González–Duarte, A., Sekijima, Y., … Gillmore, J. (2023). C66 PRIMARY RESULTS FROM APOLLO–B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN–MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY. European Heart Journal Supplements, 25(Supplement_D), D28–D28. https://doi.org/10.1093/eurheartjsupp/suad111.065

Longhi(on Behalf Of), S., Maurer, M. S., Fontana, M., Berk, J. L., Gustafsson, F., Simões, M., Grogan, M., Fernandes, F., Gottlieb, R. L., Kubanek, M., Poulsen, S., Damy, T., Diemberger, I., Tahara, N., Yu, W., Wilson Tang, W. H., Obici, L., González-duarte, A., Sekijima, Y., … Gillmore, J. D. (2022). 137 PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY. European Heart Journal Supplements, 24(Supplement_K). https://doi.org/10.1093/eurheartjsupp/suac121.630

Mussinelli(on Behalf Of The Authors), R., Garcia-pavia, P., Gillmore, J. D., Kale, P., Berk, J. L., Maurer, M. S., Conceição, I., Dicarli, M., Solomon, S., Chen, C., Arum, S., Vest, J., & Grogan, M. (2022). 77 HELIOS-A: 18-MONTH EXPLORATORY CARDIAC RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS. European Heart Journal Supplements, 24(Supplement_K). https://doi.org/10.1093/eurheartjsupp/suac121.654

Reza, N., Nayak, A., Lewsey, S. C., & DeFilippis, E. M. (2022). Representation matters: a call for inclusivity and equity in heart failure clinical trials. European Heart Journal Supplements, 24(Supplement_L), L45–L48. https://doi.org/10.1093/eurheartjsupp/suac115